Login | New Member? Signup Free
ChangeDetect » News

Congress Questions India Pharma Patent Practices

India is again coming under attack for its pharmaceutical patent policies, which Big Pharma says tilt in generic drug makers’ favor.

Tags: , , , , , ,

IP environment deteriorating in India: US pharma industry

The US pharma industry has expressed concern over deteriorating intellectual property environment in India, alleging that patent rights in the country are unreasonably denied.The US pharma industry has expressed concern over deteriorating intellectual property environment in India, alleging that patent rights in the country are unreasonably denied.

Tags: , , , ,

Setback for Idenix Pharma

Idenix Pharma suffered a setback when the USPTO issued a verdict against it.

Tags: , , ,

Horizon Pharma Announces the U.S. Patent and Trademark Office Issued an Additional Notice of Allowance With Claims

DEERFIELD, IL–(Marketwire – Feb 6, 2013) – Horizon Pharma, Inc. today announced that Skyepharma has received a Notice of Allowance from the United States Patent and Trademark Office for U.S. Patent Application 13/428,548 entitled "Delayed Release Tablet with Defined Core Geometry" that covers the Company's U.S. approved product RAYOS ® .

Tags: , , , , , , , , , , , , , , , , ,

Intec Phama wins US patent for accordion capsule

Last week, Intec Pharma announced successful results in the Phase II study of its Levodopa accordion capsule for the treatment of advanced Parkinson's Disease.

Tags: , , , , , , ,

Big Pharma lobbies hard to curb generics

India's tag of 'pharmacy of the developing world' is at a serious threat.Not only has the US devised new treaties to challenge generic drugs being shipped from India, the EU has also upped the ante.

Tags: , , , , , , ,

Endo Pharma to Shell Out $15M – Analyst Blog

Following the decision of the US patent and trademark office to extend the patent protection of BioDelivery Sciences International 's pain candidate BEMA buprenorphine by seven

Tags: , , , , , , , , , ,